City of Hope Orange County Lennar Foundation Cancer Center

Irvine, CA

Sorting 1 by

Accepting patients

JNJ-79635322

Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis
Learn more
  • BCMA
  • GPRC5D
  • Tri-specific Antibody
  • Phase 1
  • Myeloma Service